DRUG · Unmapped registry intervention
apomorphine HCl injection
Find medicine records ·
Find other trials using this name
Clinical trial
A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
NCT00145171
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson Diseaseverified · MONDO: Parkinson disease
Interventions
Sponsors & collaborators
Mylan Bertek Pharmaceuticalslead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00145171 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.